Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
DOCUSIGN, INC. director Mary Agnes Wilderotter acquired 729 shares of common stock through the exercise and conversion of Restricted Stock Units on February 28, 2026 at a price of $0.00 per share. Following this transaction, she directly holds 59,803 common shares.
Each RSU represents a right to receive one share of common stock. These RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to her continued service. The RSUs do not expire; they either vest or are canceled before vesting.
DocuSign director James A. Beer reported mixed insider activity. On March 3, 2026, he sold 450 shares of common stock in an open-market trade at $45.02 per share under a pre-arranged Rule 10b5-1 plan. On February 28, 2026, he acquired 729 shares of common stock from the conversion of 729 Restricted Stock Units. Following these transactions, he directly held 14,757 common shares, with an additional 5,543 shares held indirectly by a trust.
DOCUSIGN, INC. director Cain A. Hayes reported an equity award conversion rather than an open-market trade. On February 28, 2026, 729 Restricted Stock Units were exercised at $0.00 per unit, delivering 729 shares of common stock.
Following this transaction, Hayes directly owned 14,988 shares of DocuSign common stock. A separate line shows 729 Restricted Stock Units remaining directly held, each representing a contingent right to receive one share of common stock, subject to the disclosed vesting conditions.
DOCUSIGN, INC. director Michael George Rosenbaum reported the exercise or conversion of restricted stock units into common stock. On March 3, 2026, he exercised 522 restricted stock units at a price of $0.0000 per unit, receiving 522 shares of common stock. After these transactions, he directly held 5,221 restricted stock units and 1,044 shares of common stock. Each RSU represents the right to receive one share of common stock and will vest in twelve equal quarterly installments over three years starting on September 3, 2025, as long as he continues as a service provider.
DOCUSIGN, INC. director Anna Marrs reported mixed share activity. On March 3, 2026, she executed an open-market sale of 365 shares of common stock at $45.02 per share under a pre-arranged Rule 10b5-1 plan, leaving 11,889 shares of common stock directly owned.
On February 28, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 shares of common stock. Each RSU represents one share, with RSUs scheduled to vest quarterly starting May 29, 2025 over one year, subject to continued service, and they either vest or are canceled rather than expiring.
Anna Marrs reported an intended sale of 365 shares of common stock of DOCU as restricted stock, dated 02/28/2026, with the filing dated 03/03/2026. The filing notes prior sales of 363 shares on 12/05/2025 for $23,413.50.
DocuSign, Inc. director Teresa Briggs reported an open-market sale of common stock. On February 27, 2026, she sold 364 shares at an average price of $44.31 per share under a pre-arranged Rule 10b5-1 trading plan. Following this planned sale, she directly owns 9,170 shares of DocuSign common stock.
Teresa Briggs reported proposed sales of Common stock via a Form 144 filing. The filing lists restricted stock entries dated 05/29/2025 (340) and 02/28/2025 (24). It also records securities sold during the past 3 months showing a sale on 11/28/2025 with the entries 365 and 25254.35 as presented in the notice.
JPMorgan Chase & Co. filed a Schedule 13G reporting beneficial ownership of 13,712,039 shares of DocuSign, Inc. common stock, representing 6.4% of the outstanding class as of 12/31/2025. JPMorgan has sole power to vote and dispose of all these shares and no shared voting or dispositive power. The filing classifies JPMorgan as a parent holding company and lists several subsidiaries involved in holding the securities. JPMorgan certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of DocuSign.